Petros Grivas, Professor at University of Washington and Fred Hutch, shared Sumanta K. Pal’s, Vice Chair of Academic Affairs and Professor at City of Hope, post on X, adding:
“Congrats Koral Shah, Salvador Jaime-Casas, Ruchi Agarwal, Sumanta K. Pal et al. for so important paper highlighting relevant disparities in trials availability and stimulating ‘implementation science’ interventions.”
Quoting Sumanta K. Pal’s post:
“Tremendous work from a team led by Koral Shah, Salvador Jaime-Casas and Ruchi Agarwal, co-first authors on this piece in JAMA Network Open highlighting the regional variations in bladder cancer trials in the US.
Their detailed analysis of regional variations in study availability points to a misalignment between trial access and disease burden. Tagging IBCG, Bladder Cancer Advocacy Network and other groups fighting for access to clinical trials for our patients.”
You can also read: Etentamig Improves Response Rate and PFS in Phase 3 CERVINO Multiple Myeloma Trial
